11/7/24 16:38 | 11/6/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | S | -456 | 91.28 | 0 | -5 | -6 | 73 | D | | | | | | | | | | | | | | |
9/13/24 17:08 | 9/12/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | S | -2,460 | 83.78 | 0 | -29 | -27 | 78 | D | | | | | | | | | | | | | | |
9/11/24 19:23 | 9/10/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 4 | 4 | 107 | D | | | | | | | | | | | | | | |
8/29/24 15:23 | 8/28/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | S | -742 | 78.03 | 0 | -10 | -8 | 105 | D | | | | | | | | | | | | | | |
8/14/24 14:23 | 8/13/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | S | -406 | 73.98 | 0 | -5 | -5 | 115 | D | | | | | | | | | | | | | | |
6/11/24 19:18 | 6/10/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 4 | 3 | 120 | D | | | | | | | | | | | | | | |
5/21/24 16:46 | 5/17/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | D | | M.d | 0 | 0.00 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
3/11/24 21:03 | 3/10/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 10 | 9 | 118 | D | | | | | | | | | | | | | | |
1/10/24 15:58 | 1/9/24 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | S | -702 | 85.23 | 0 | -8 | -9 | 83 | D | | | | | | | | | | | | | | |
12/11/23 19:15 | 12/10/23 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 3 | 3 | 91 | D | | | | | | | | | | | | | | |
9/11/23 20:44 | 9/10/23 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 3 | 3 | 89 | D | | | | | | | | | | | | | | |
7/25/23 18:15 | 7/24/23 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 8 | 18 | 48 | D | | | | | | | | | | | | | | |
6/12/23 16:39 | 6/10/23 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 3 | 7 | 44 | D | | | | | | | | | | | | | | |
3/13/23 21:00 | 3/10/23 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 11 | 15 | 82 | D | | | | | | | | | | | | | | |
12/13/22 15:12 | 12/10/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 1 | 3 | 40 | D | | | | | | | | | | | | | | |
9/12/22 16:08 | 9/10/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 1 | 3 | 40 | D | | | | | | | | | | | | | | |
7/26/22 12:31 | 7/24/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 8 | 24 | 39 | D | | | | | | | | | | | | | | |
6/13/22 20:08 | 6/10/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 1 | 3 | 35 | D | | | | | | | | | | | | | | |
3/14/22 21:14 | 3/10/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 7 | 25 | 35 | D | | | | | | | | | | | | | | |